Gentrix™ Versus Biological or Prosthetic Mesh
Randomized, Controlled Trial Comparing Separation of Components Repair With Retrorectus Gentrix™ Surgical Matrix Versus Biological or Prosthetic Mesh for Open Ventral Hernia Repair
Sponsor: Integra LifeSciences Corporation
Terminated
Cease of Funding
Other terminated trials from Integra LifeSciences Corporation
- Peripheral Nerve Injuries · Jun 2024
- Digital Nerve Injury · Phase NA · May 2024
- Ventral Incisional Hernia · Jun 2021
- Diabetes · Phase NA · Feb 2020
- Wounds · Jan 2020
More terminations from Integra LifeSciences Corporation
Other Ventral Incisional Hernia trials with similar outcome
A NA clinical study on Ventral Incisional Hernia, this trial is terminated or withdrawn. The trial is conducted by Integra LifeSciences Corporation and has accumulated 10 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Oct 2021 — Jul 2024 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Feb 2020 — Apr 2020 [monthly]
Recruiting NA
-
Apr 2019 — Feb 2020 [monthly]
Recruiting NA
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Oct 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Integra LifeSciences Corporation
- University of South Florida
For direct contact, visit the study record on ClinicalTrials.gov .